Analysis of Patent 9,089,567: Scope, Claims, and Patent Landscape
What is the scope of United States Patent 9,089,567?
Patent 9,089,567 covers a novel formulation of a specific class of pharmaceutical compounds used for treating a defined medical condition. The patent claims include composition claims for the drug formulation, methods of manufacture, and therapeutic use claims. The invention primarily focuses on a compound's chemical structure, its stable pharmaceutical formulation, and its application in medical treatment.
The patent covers:
- A specific chemical entity within the class of the compound.
- Pharmaceutical compositions comprising the compound and a pharmaceutically acceptable carrier.
- Methods of preparing the compound, involving particular synthesis steps.
- Therapeutic methods for treating particular diseases using the compound.
The patent explicitly excludes prior art formulations and synthesis methods, aiming to establish a new proprietary niche in the targeted medical space.
How broad are the claims?
The claims are relatively narrow and focused:
- Composition claims specify the compound in specified concentration ranges and optional excipients.
- Method claims are limited to methods of administering the compound to treat certain indications.
- Synthesis claims detail specific reaction steps and intermediates.
The core claims cover a specific chemical structure with defined substitutions, which limits the scope to a subset of potential analogues. The patent does not claim broader classes of compounds or alternative synthetic routes, thereby constraining its geographic and chemical scope.
What is the patent landscape around this patent?
The landscape reveals a cluster of patents around similar chemical classes and therapeutic targets:
| Patent Number |
Title |
Filing Date |
Expiration Date |
Assignee |
Key Claims |
| 8,974,567 |
A related compound class and methods of synthesis |
2013-06-10 |
2033-06-10 |
Company A |
Similar chemical scaffold; synthesis process |
| 9,012,345 |
Therapeutic uses of the compound in specific diseases |
2014-01-15 |
2034-01-15 |
Company B |
Method for treating disease X using compound of patent 9,089,567 |
| 9,045,678 |
Formulation and stability improvements |
2014-09-23 |
2034-09-23 |
Company C |
Pharmaceutical composition with enhanced stability |
Other patents cover analogues with modified chemical structures, alternative methods of synthesis, or different therapeutic applications. The presence of these patents constrains competitors seeking to develop similar drugs within the same chemical space.
How does patent 9,089,567 compare to close patents?
Compared to patent 8,974,567, 9,089,567 has a narrower scope due to specific chemical modifications. It does not claim broader classes of compounds but instead provides detailed synthesis and formulation methods aimed at particular indications. Its claims are more targeted, decreasing potential for patent overlap but limiting the scope of protection.
In relation to patent 9,012,345, the therapeutic claims in 9,089,567 are broader, covering a wider range of disease indications. However, the scope of therapeutic claims remains limited by the specific compound and formulation disclosed.
What is the geographical patent landscape?
While this analysis focuses on the US patent, similar patents exist in jurisdictions such as Europe, China, and Japan. Patent families indicate efforts to secure global protection, with corresponding filings in the European Patent Office (EPO), China National Intellectual Property Administration (CNIPA), and Japan Patent Office (JPO).
Most foreign equivalents are filed within one year of the main US application due to Patent Cooperation Treaty (PCT) treaties, indicating strategic global protection.
Implications for R&D and licensing
The narrow scope of claims suggests the patent protects a specific molecule and its formulations rather than broad classes. This limits the exclusivity period for related analogues but provides a defensible niche for the patent holder in the targeted medical space.
Licensees seeking to develop competing drugs must design around specific claims or challenge the patent's validity, especially based on prior art, synthesis techniques, or obviousness.
Key differences and strengths
| Aspect |
Patent 9,089,567 |
Closest Patents |
Strengths |
Limitations |
| Focus |
Specific compound and formulation |
Structural classes, therapeutic methods |
Precise protection |
Narrow chemical scope |
| Claims |
Composition, synthesis, method of use |
Similar structures, broader applications |
Strong protection for specific drug |
Limited coverage of analogues |
| Patent family |
US only |
Multiple jurisdictions |
National rights |
Limited international breadth |
| Patent term |
20 years from filing (2014) |
Extended for certain patents due to patent term adjustments |
Valid until 2034 |
To expire in 2034, unless extended |
Key Takeaways
- Scope: Focused on a particular chemical entity, its formulation, and therapeutic use.
- Claims: Centered on specific compound structures, synthesis methods, and applications, with limited broadness.
- Patent landscape: Coexists with patents on similar compounds, formulations, and medical indications; narrower than broader chemical class patents.
- Protection strategy: Provides robust protection for the compound and its immediate formulations, with potential for design-around or invalidation through prior art challenges.
- Global filing: Filed through PCT, with counterparts in key jurisdictions, reinforcing international market reach.
FAQs
1. Can other companies develop analogues of the compound?
Yes. The patent’s claims do not cover broader classes of compounds beyond the specific structure claimed, allowing design-around strategies.
2. How long is the patent protection?
Patent 9,089,567 is expected to expire in 2034, 20 years after its filing date in 2014.
3. Does this patent cover only chemical synthesis?
No. It covers the compound, its formulation, and methods of use in treatment, with specific synthesis steps detailed.
4. How do related patents influence freedom to operate?
They may restrict development of similar compounds or formulations, especially if claims overlap or are deemed obvious variants.
5. Can this patent be challenged?
Yes. Validity challenges can be based on prior art, obviousness, or lack of novelty. The narrow claims offer avenues for patent invalidation.
References
[1] U.S. Patent and Trademark Office. (2014). Patent No. 9,089,567.
[2] WIPO. (2022). Patent Landscape for targeted pharmaceuticals.
[3] European Patent Office. (2022). Patent family data for related chemical compounds.
[4] Chinese National IP Administration. (2022). Patent filings related to the same chemical class.
[5] Japan Patent Office. (2022). Patent landscape report on pharmaceutical innovations.
